Lupin informs about press release

09 Mar 2021 Evaluate

Lupin has informed that it has enclosed is a Press Release on 9th March 2021 titled ‘Lupin Pharma Canada Announces Partnership with Endoceutics for the commercialization of Intrarosa®’as regards Lupin Pharma Canada, Canada/wholly owned subsidiary of the Company having entered into partnership with Endoceutics, a women's health focused innovative Canadian biotech company, to commercialize Intrarosa® in Canada indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×